ONS 41st Annual Congress

The Working Group to Personalize Multidisciplinary Care in Patients with Lung Cancer: Updates and Evolving Concepts for Nurses symposium features oncology nurses and physician peers discussing challenges in testing for epidermal growth factor receptor (EGFR) mutations, choosing an EGFR tyrosine kinase inhibitor (TKI), managing adverse events, addressing resistance to therapy, and the role of next-generation EGFR TKIs. Interactive case-based discussions will allow attendees to apply clinical evidence and expert opinion to patient care scenarios.

Co-Chairs 

 

Benjamin Levy, MD
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program, Mount Sinai Health Systems
Associate Director, Cancer Clinical Trials Office, Mount Sinai Hospital
Mount Sinai Hospital
New York, NY   

 

Karen Lee, MSN, FNP-BC
Mount Sinai Hospital
New York, NY 

Faculty 

 

Laura Brennan FNP-c, AOCNP
Division of Hematology & Oncology
UC Davis Medical Center
Sacramento, CA   

 

Ann Culkin, RN, OCN
Department of Nursing
Office Practice Nurse, Outpatient Thoracic Service
Memorial Sloan Kettering Cancer Center
New York, NY   

 

Alexander E. Drilon, MD
Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY   

 

Jonathan Riess, MD, MS
Assistant Professor of Medicine
Division of Hematology Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA 

This activity is supported by educational grants from AstraZeneca. 

Please click here to register for this event.